Literature DB >> 17952124

Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.

B I Ferreira1, J Alonso, J Carrillo, F Acquadro, C Largo, J Suela, M R Teixeira, N Cerveira, A Molares, G Goméz-López, A Pestaña, A Sastre, P Garcia-Miguel, J C Cigudosa.   

Abstract

Ewing's sarcoma (ES) is characterized by specific chromosome translocations, the most common being t(11;22)(q24;q12). Additionally, other type of genetic abnormalities may occur and be relevant for explaining the variable tumour biology and clinical outcome. We have carried out a high-resolution array CGH and expression profiling on 25 ES tumour samples to characterize the DNA copy number aberrations (CNA) occurring in these tumours and determine their association with gene-expression profiles and clinical outcome. CNA were observed in 84% of the cases. We observed a median number of three aberrations per case. Besides numerical chromosome changes, smaller aberrations were found and defined at chromosomes 5p, 7q and 9p. All CNA were compiled to define the smallest overlapping regions of imbalance (SORI). A total of 35 SORI were delimited. Bioinformatics analyses were conducted to identify subgroups according to the pattern of genomic instability. Unsupervised and supervised clustering analysis (using SORI as variables) segregated the tumours in two distinct groups: one genomically stable (< or =3 CNA) and other genomically unstable (>3 CNA). The genomic unstable group showed a statistically significant shorter overall survival and was more refractory to chemotherapy. Expression profile analysis revealed significant differences between both groups. Genes related with chromosome segregation, DNA repair pathways and cell-cycle control were upregulated in the genomically unstable group. This report elucidates, for the first time, data about genomic instability in ES, based on CNA and expression profiling, and shows that a genomically unstable group of Ewing's tumours is correlated with a significant poor prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17952124     DOI: 10.1038/sj.onc.1210845

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Characterization of KRAS rearrangements in metastatic prostate cancer.

Authors:  Xiao-Song Wang; Sunita Shankar; Saravana M Dhanasekaran; Bushra Ateeq; Atsuo T Sasaki; Xiaojun Jing; Daniel Robinson; Qi Cao; John R Prensner; Anastasia K Yocum; Rui Wang; Daniel F Fries; Bo Han; Irfan A Asangani; Xuhong Cao; Yong Li; Gilbert S Omenn; Dorothee Pflueger; Anuradha Gopalan; Victor E Reuter; Emily Rose Kahoud; Lewis C Cantley; Mark A Rubin; Nallasivam Palanisamy; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

2.  Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.

Authors:  Barbara S Paugh; Chunxu Qu; Chris Jones; Zhaoli Liu; Martyna Adamowicz-Brice; Junyuan Zhang; Dorine A Bax; Beth Coyle; Jennifer Barrow; Darren Hargrave; James Lowe; Amar Gajjar; Wei Zhao; Alberto Broniscer; David W Ellison; Richard G Grundy; Suzanne J Baker
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

Review 3.  Molecular profiling of sarcomas: new vistas for precision medicine.

Authors:  Tariq Al-Zaid; Wei-Lien Wang; Neeta Somaiah; Alexander J Lazar
Journal:  Virchows Arch       Date:  2017-06-29       Impact factor: 4.064

4.  Systems Biology Analysis for Ewing Sarcoma.

Authors:  Marianyela Petrizzelli; Jane Merlevede; Andrei Zinovyev
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Recent advances in the molecular pathogenesis of Ewing's sarcoma.

Authors:  E C Toomey; J D Schiffman; S L Lessnick
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

6.  waviCGH: a web application for the analysis and visualization of genomic copy number alterations.

Authors:  Angel Carro; Daniel Rico; Oscar M Rueda; Ramón Díaz-Uriarte; David G Pisano
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

7.  Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.

Authors:  Mona S Jahromi; Angelica R Putnam; Colleen Druzgal; Jennifer Wright; Holly Spraker-Perlman; Michelle Kinsey; Holly Zhou; Kenneth M Boucher; R Lor Randall; Kevin B Jones; David Lucas; Andrew Rosenberg; Dafydd Thomas; Stephen L Lessnick; Joshua D Schiffman
Journal:  Cancer Genet       Date:  2012 Jul-Aug

8.  Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma.

Authors:  Georges Maire; Maisa Yoshimoto; Susan Chilton-MacNeill; Paul S Thorner; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

Review 9.  Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.

Authors:  Andrew H Beck; Robert B West; Matt van de Rijn
Journal:  Virchows Arch       Date:  2009-05-02       Impact factor: 4.064

10.  Combining chromosomal arm status and significantly aberrant genomic locations reveals new cancer subtypes.

Authors:  Tal Shay; Wanyu L Lambiv; Anat Reiner-Benaim; Monika E Hegi; Eytan Domany
Journal:  Cancer Inform       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.